Ingrid Torjesen is a freelance journalist specialising in health and health policy. She is a regular contributor to The BMJ and the Health Service Journal and is editor of The Advisor, a magazine for people working in smoking cessation services. In the past she has acted as news editor for The BMJ; opinion, features and news editors for the HSJ and features editor for Nursing Times. Staff posts include associate editor and news editor of GP newspaper, news editor of Pulse, and reporter at Australian Doctor, based in Sydney. She has a degree in Biological Sciences specialising in Genetics.
Meta-analysis of studies suggest that patients who receive gastric acid drugs may be at increased risk for recurrent Clostridium difficile infection.
Researchers find that blood clot rates in patients taking rivaroxaban were significantly lower than those taking aspirin, and there were no significant differences between bleeding side effects.
Patients could have to wait up to two years longer to access new cancer drugs after the UK leaves the EU, because drug companies will prioritise winning approval for access to the larger European market, experts have warned.
The Murray review: moving in the right directionSubscription